Biotech Series A Investors & VC Firms
1626 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.
CU Healthcare Innovation Fund
AuroraSeed–Series A
6 people
Daesung Private Equity
SeoulSeed–Series A
Solasta Ventures
BostonSeed–Series B
6 people
Visionary Ventures
Newport BeachSeries A–Growth$5M – $15M
9 people
Bharat Fund
AhmedabadSeed–Series A
11 people
Cross-Border Impact Ventures
TorontoSeries A–Series B$2M – $10M
11 people
Harbor Light Capital Partners
KeeneSeed–Series A$1M – $5M
8 people
EIR Ventures
StockholmSeed–Series A
10 people
Export and Investment Fund
CopenhagenSeed–Growth$108K – $7.6M
13 people
Leva Capital
TorontoPre-Seed–Series A
16 people
Ohio Innovation Fund
DublinSeed–Series A$500K – $4M
4 people
Tensor Ventures
SenningerbergSeed–Series A
10 people
Capagro
ParisSeries A–Growth$2.2M – $6.6M
9 people
DC Investment Partners
McLeanSeed–Growth$10M
10 people
3xP Global
LisbonSeries A–Series B$1.1M – $10.8M
5 people
Boundary Capital
NorthamptonSeed–Series A$190.5K – $635K
5 people
Braven
New YorkSeed–Series A
17 people
Ying Fund
Los AngelesSeed–Series A
8 people
Perivoli Innovations
St. HelierPre-Seed–Series A
2 people
Humboldt
New YorkPre-Seed–Series A$100K – $5M
4 people
Maxpro Ventures
TaipeiSeed–Late Stage
7 people
Finchley Healthcare Ventures
MontrealSeed–Series A
15 people
Healthtech Capital
Silicon ValleySeed–Series A
3 people
ORI Capital
Hong KongSeed–Series A
15 people
Related lists
Series A Investors & VC Firms (7325)Series A Investors & VC Firms in North America (4219)Series A Investors & VC Firms in United States (3838)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2590)Biotech Investors & VC Firms (2475)Series A Investors & VC Firms in Europe (2383)Fintech Series A Investors & VC Firms (2349)Healthtech Series A Investors & VC Firms (2309)Enterprise Software Series A Investors & VC Firms (2264)
Data sourced from public filings and firms' own websites — see our methodology.





















































































